1
|
Che Z, Sun Q, Zhao Z, Wu Y, Xing H, Song K, Chen A, Wang B, Cai M. Growth factor-functionalized titanium implants for enhanced bone regeneration: A review. Int J Biol Macromol 2024; 274:133153. [PMID: 38897500 DOI: 10.1016/j.ijbiomac.2024.133153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Revised: 06/02/2024] [Accepted: 06/12/2024] [Indexed: 06/21/2024]
Abstract
Titanium and titanium alloys are widely favored materials for orthopedic implants due to their exceptional mechanical properties and biological inertness. The additional benefit of sustained local release of bioactive substances further promotes bone tissue formation, thereby augmenting the osseointegration capacity of titanium implants and attracting increasing attention in bone tissue engineering. Among these bioactive substances, growth factors have shown remarkable osteogenic and angiogenic induction capabilities. Consequently, researchers have developed various physical, chemical, and biological loading techniques to incorporate growth factors into titanium implants, ensuring controlled release kinetics. In contrast to conventional treatment modalities, the localized release of growth factors from functionalized titanium implants not only enhances osseointegration but also reduces the risk of complications. This review provides a comprehensive examination of the types and mechanisms of growth factors, along with a detailed exploration of the methodologies used to load growth factors onto the surface of titanium implants. Moreover, it highlights recent advancements in the application of growth factors to the surface of titanium implants (Scheme 1). Finally, the review discusses current limitations and future prospects for growth factor-functionalized titanium implants. In summary, this paper presents cutting-edge design strategies aimed at enhancing the bone regenerative capacity of growth factor-functionalized titanium implants-a significant advancement in the field of enhanced bone regeneration.
Collapse
Affiliation(s)
- Zhenjia Che
- Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, People's Republic of China.
| | - Qi Sun
- Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, People's Republic of China
| | - Zhenyu Zhao
- Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, People's Republic of China
| | - Yanglin Wu
- Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, People's Republic of China
| | - Hu Xing
- Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, People's Republic of China
| | - Kaihang Song
- Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, People's Republic of China
| | - Aopan Chen
- Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, People's Republic of China
| | - Bo Wang
- Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, People's Republic of China.
| | - Ming Cai
- Department of Orthopaedics, Shanghai Tenth People's Hospital, Tongji University School of Medicine, No. 301 Middle Yanchang Road, Shanghai 200072, People's Republic of China.
| |
Collapse
|
2
|
Haidar LL, Bilek M, Akhavan B. Surface Bio-engineered Polymeric Nanoparticles. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2024; 20:e2310876. [PMID: 38396265 DOI: 10.1002/smll.202310876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Revised: 02/05/2024] [Indexed: 02/25/2024]
Abstract
Surface bio-engineering of polymeric nanoparticles (PNPs) has emerged as a cornerstone in contemporary biomedical research, presenting a transformative avenue that can revolutionize diagnostics, therapies, and drug delivery systems. The approach involves integrating bioactive elements on the surfaces of PNPs, aiming to provide them with functionalities to enable precise, targeted, and favorable interactions with biological components within cellular environments. However, the full potential of surface bio-engineered PNPs in biomedicine is hampered by obstacles, including precise control over surface modifications, stability in biological environments, and lasting targeted interactions with cells or tissues. Concerns like scalability, reproducibility, and long-term safety also impede translation to clinical practice. In this review, these challenges in the context of recent breakthroughs in developing surface-biofunctionalized PNPs for various applications, from biosensing and bioimaging to targeted delivery of therapeutics are discussed. Particular attention is given to bonding mechanisms that underlie the attachment of bioactive moieties to PNP surfaces. The stability and efficacy of surface-bioengineered PNPs are critically reviewed in disease detection, diagnostics, and treatment, both in vitro and in vivo settings. Insights into existing challenges and limitations impeding progress are provided, and a forward-looking discussion on the field's future is presented. The paper concludes with recommendations to accelerate the clinical translation of surface bio-engineered PNPs.
Collapse
Affiliation(s)
- Laura Libnan Haidar
- School of Physics, University of Sydney, Sydney, NSW, 2006, Australia
- The University of Sydney Nano Institute, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Marcela Bilek
- School of Physics, University of Sydney, Sydney, NSW, 2006, Australia
- The University of Sydney Nano Institute, The University of Sydney, Sydney, NSW, 2006, Australia
- School of Biomedical Engineering, University of Sydney, Sydney, NSW, 2006, Australia
- Charles Perkins Centre, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Behnam Akhavan
- School of Physics, University of Sydney, Sydney, NSW, 2006, Australia
- The University of Sydney Nano Institute, The University of Sydney, Sydney, NSW, 2006, Australia
- School of Biomedical Engineering, University of Sydney, Sydney, NSW, 2006, Australia
- School of Engineering, University of Newcastle, Callaghan, NSW, 2308, Australia
- Hunter Medical Research Institute (HMRI), Precision Medicine Program, New Lambton Heights, NSW, 2305, Australia
| |
Collapse
|
3
|
Antibacterial Ti-Cu implants: A critical review on mechanisms of action. Mater Today Bio 2022; 17:100447. [PMID: 36278144 PMCID: PMC9579810 DOI: 10.1016/j.mtbio.2022.100447] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2022] [Revised: 09/28/2022] [Accepted: 09/29/2022] [Indexed: 11/06/2022] Open
Abstract
Titanium (Ti) has been widely used for manufacturing of bone implants because of its mechanical properties, biological compatibility, and favorable corrosion resistance in biological environments. However, Ti implants are prone to infection (peri-implantitis) by bacteria which in extreme cases necessitate painful and costly revision surgeries. An emerging, viable solution for this problem is to use copper (Cu) as an antibacterial agent in the alloying system of Ti. The addition of copper provides excellent antibacterial activities, but the underpinning mechanisms are still obscure. This review sheds light on such mechanisms and reviews how incorporation of Cu can render Ti–Cu implants with antibacterial activity. The review first discusses the fundamentals of interactions between bacteria and implanted surfaces followed by an overview of the most common engineering strategies utilized to endow an implant with antibacterial activity. The underlying mechanisms for antibacterial activity of Ti–Cu implants are then discussed in detail. Special attention is paid to contact killing mechanisms because the misinterpretation of this mechanism is the root of discrepancies in the literature.
Collapse
|
4
|
Miri L, Irani S, Pezeshki-Modaress M, Daemi H, Atyabi SM. Guiding mesenchymal stem cells differentiation into chondrocytes using sulfated alginate/cold atmospheric plasma modified polycaprolactone nanofibrous scaffold. Polym Bull (Berl) 2022. [DOI: 10.1007/s00289-022-04476-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
Wahed SB, Dunstan CR, Boughton PA, Ruys AJ, Faisal SN, Wahed TB, Salahuddin B, Cheng X, Zhou Y, Wang CH, Islam MS, Aziz S. Functional Ultra-High Molecular Weight Polyethylene Composites for Ligament Reconstructions and Their Targeted Applications in the Restoration of the Anterior Cruciate Ligament. Polymers (Basel) 2022; 14:polym14112189. [PMID: 35683861 PMCID: PMC9182730 DOI: 10.3390/polym14112189] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2022] [Revised: 05/20/2022] [Accepted: 05/25/2022] [Indexed: 11/16/2022] Open
Abstract
The selection of biomaterials as biomedical implants is a significant challenge. Ultra-high molecular weight polyethylene (UHMWPE) and composites of such kind have been extensively used in medical implants, notably in the bearings of the hip, knee, and other joint prostheses, owing to its biocompatibility and high wear resistance. For the Anterior Cruciate Ligament (ACL) graft, synthetic UHMWPE is an ideal candidate due to its biocompatibility and extremely high tensile strength. However, significant problems are observed in UHMWPE based implants, such as wear debris and oxidative degradation. To resolve the issue of wear and to enhance the life of UHMWPE as an implant, in recent years, this field has witnessed numerous innovative methodologies such as biofunctionalization or high temperature melting of UHMWPE to enhance its toughness and strength. The surface functionalization/modification/treatment of UHMWPE is very challenging as it requires optimizing many variables, such as surface tension and wettability, active functional groups on the surface, irradiation, and protein immobilization to successfully improve the mechanical properties of UHMWPE and reduce or eliminate the wear or osteolysis of the UHMWPE implant. Despite these difficulties, several surface roughening, functionalization, and irradiation processing technologies have been developed and applied in the recent past. The basic research and direct industrial applications of such material improvement technology are very significant, as evidenced by the significant number of published papers and patents. However, the available literature on research methodology and techniques related to material property enhancement and protection from wear of UHMWPE is disseminated, and there is a lack of a comprehensive source for the research community to access information on the subject matter. Here we provide an overview of recent developments and core challenges in the surface modification/functionalization/irradiation of UHMWPE and apply these findings to the case study of UHMWPE for ACL repair.
Collapse
Affiliation(s)
- Sonia B. Wahed
- School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia; (C.R.D.); (P.A.B.); (A.J.R.); (X.C.)
- Correspondence: (S.B.W.); (S.A.)
| | - Colin R. Dunstan
- School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia; (C.R.D.); (P.A.B.); (A.J.R.); (X.C.)
| | - Philip A. Boughton
- School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia; (C.R.D.); (P.A.B.); (A.J.R.); (X.C.)
| | - Andrew J. Ruys
- School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia; (C.R.D.); (P.A.B.); (A.J.R.); (X.C.)
| | - Shaikh N. Faisal
- ARC Centre of Excellence for Electromaterials Science & Intelligent Polymer Research Institute, Australian Institute of Innovative Materials, University of Wollongong, Wollongong, NSW 2522, Australia;
| | - Tania B. Wahed
- Department of Pharmacy, Jahangirnagar University, Savar 1342, Bangladesh;
| | - Bidita Salahuddin
- School of Chemical Engineering, The University of Queensland, Brisbane, QLD 4072, Australia;
| | - Xinying Cheng
- School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia; (C.R.D.); (P.A.B.); (A.J.R.); (X.C.)
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, NSW 2052, Australia; (Y.Z.); (C.H.W.); (M.S.I.)
| | - Yang Zhou
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, NSW 2052, Australia; (Y.Z.); (C.H.W.); (M.S.I.)
| | - Chun H. Wang
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, NSW 2052, Australia; (Y.Z.); (C.H.W.); (M.S.I.)
| | - Mohammad S. Islam
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, NSW 2052, Australia; (Y.Z.); (C.H.W.); (M.S.I.)
| | - Shazed Aziz
- School of Chemical Engineering, The University of Queensland, Brisbane, QLD 4072, Australia;
- Correspondence: (S.B.W.); (S.A.)
| |
Collapse
|
6
|
Pearson JJ, Temenoff JS. Growth Factor Immobilization Strategies for Musculoskeletal Disorders. Curr Osteoporos Rep 2022; 20:13-25. [PMID: 35118607 PMCID: PMC10772941 DOI: 10.1007/s11914-022-00718-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/22/2021] [Indexed: 11/30/2022]
Abstract
PURPOSE OF REVIEW Tissue regenerative solutions for musculoskeletal disorders have become increasingly important with a growing aged population. Current growth factor treatments often require high dosages with the potential for off-target effects. Growth factor immobilization strategies offer approaches towards alleviating these concerns. This review summarizes current growth factor immobilization techniques (encapsulation, affinity interactions, and covalent binding) and the effects of immobilization on growth factor loading, release, and bioactivity. RECENT FINDINGS The breadth of immobilization techniques based on encapsulation, affinity, and covalent binding offer multiple methods to improve the therapeutic efficacy of growth factors by controlling bioactivity and release. Growth factor immobilization strategies have evolved to more complex systems with the capacity to load and release multiple growth factors with spatiotemporal control. The advancements in immobilization strategies allow for development of new, complex musculoskeletal tissue treatment strategies with improved spatiotemporal control of loading, release, and bioactivity.
Collapse
Affiliation(s)
- Joseph J Pearson
- W.H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, Atlanta, GA, 30332, USA
| | - Johnna S Temenoff
- W.H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, 313 Ferst Drive, Atlanta, GA, 30332, USA.
- Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, 315 Ferst Drive, Atlanta, GA, 30332, USA.
| |
Collapse
|
7
|
Kim S, Chen JB, Clifford A. Tuning the Biointerface: Low-Temperature Surface Modification Strategies for Orthopedic Implants to Enhance Osteogenic and Antimicrobial Activity. ACS APPLIED BIO MATERIALS 2021; 4:6619-6629. [PMID: 35006965 DOI: 10.1021/acsabm.1c00651] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
As both the average life expectancy and incidence of bone tissue reconstruction increases, development of load-bearing implantable materials that simultaneously enhance osseointegration while preventing postoperative infection is crucial. To address this need, significant research efforts have been dedicated to developing surface modification strategies for metallic load-bearing implants and scaffolds. Despite the abundance of strategies reported, many address only one factor, for example, surface chemistry or topography. Furthermore, the incorporation of surface features to increase osteocompatibility can increase the probability of infection, by encouraging the formation of bacterial biofilms. To truly advance this field, research efforts must focus on developing multifunctional coatings that concurrently address these complex and competing requirements. In addition, particular emphasis should be placed on utilizing surface modification processes that are versatile, low cost, and scalable, for ease of translation to mass manufacturing and clinical use. The aim of this short Review is to highlight recent advances in scalable and multifunctional surface modification techniques that obtain a programmed response at the bone tissue/implant interface. Low-temperature approaches based on macromolecule immobilization, electrochemical techniques, and solution processes are discussed. Although the strategies discussed in this Review have not yet been approved for clinical use, they show great promise toward developing the next generation of ultra-long-lasting biomaterials for joint and bone tissue repair.
Collapse
Affiliation(s)
- Saeromi Kim
- Department of Materials Engineering, Faculty of Applied Science, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada
| | - Jenise B Chen
- Department of Chemistry, Faculty of Arts & Science, University of Toronto, Toronto, ON M5S 3H6, Canada
| | - Amanda Clifford
- Department of Materials Engineering, Faculty of Applied Science, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada
| |
Collapse
|
8
|
Oliver‐Cervelló L, Martin‐Gómez H, Reyes L, Noureddine F, Ada Cavalcanti‐Adam E, Ginebra M, Mas‐Moruno C. An Engineered Biomimetic Peptide Regulates Cell Behavior by Synergistic Integrin and Growth Factor Signaling. Adv Healthc Mater 2021; 10:e2001757. [PMID: 33336559 DOI: 10.1002/adhm.202001757] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2020] [Revised: 12/02/2020] [Indexed: 01/04/2023]
Abstract
Recreating the healing microenvironment is essential to regulate cell-material interactions and ensure the integration of biomaterials. To repair bone, such bioactivity can be achieved by mimicking its extracellular matrix (ECM) and by stimulating integrin and growth factor (GF) signaling. However, current approaches relying on the use of GFs, such as bone morphogenetic protein 2 (BMP-2), entail clinical risks. Here, a biomimetic peptide integrating the RGD cell adhesive sequence and the osteogenic DWIVA motif derived from the wrist epitope of BMP-2 is presented. The approach offers the advantage of having a spatial control over the single binding of integrins and BMP receptors. Such multifunctional platform is designed to incorporate 3,4-dihydroxyphenylalanine to bind metallic oxides with high affinity in a one step process. Functionalization of glass substrates with the engineered peptide is characterized by physicochemical methods, proving a successful surface modification. The biomimetic interfaces significantly improve the adhesion of C2C12 cells, inhibit myotube formation, and activate the BMP-dependent signaling via p38. These effects are not observed on surfaces displaying only one bioactive motif, a mixture of both motifs or soluble DWIVA. These data prove the biological potential of recreating the ECM and engaging in integrin and GF crosstalk via molecular-based mimics.
Collapse
Affiliation(s)
- Lluís Oliver‐Cervelló
- Biomaterials, Biomechanics and Tissue Engineering Group Department of Materials Science and Engineering Universitat Politècnica de Catalunya (UPC) Barcelona 08019 Spain
- Barcelona Research Center in Multiscale Science and Engineering UPC Barcelona 08019 Spain
| | - Helena Martin‐Gómez
- Biomaterials, Biomechanics and Tissue Engineering Group Department of Materials Science and Engineering Universitat Politècnica de Catalunya (UPC) Barcelona 08019 Spain
- Barcelona Research Center in Multiscale Science and Engineering UPC Barcelona 08019 Spain
| | - Leslie Reyes
- Biomaterials, Biomechanics and Tissue Engineering Group Department of Materials Science and Engineering Universitat Politècnica de Catalunya (UPC) Barcelona 08019 Spain
| | - Fatima Noureddine
- Department of Cellular Biophysics Max Planck Institute for Medical Research Jahnstraße 29 Heidelberg 69120 Germany
| | | | - Maria‐Pau Ginebra
- Biomaterials, Biomechanics and Tissue Engineering Group Department of Materials Science and Engineering Universitat Politècnica de Catalunya (UPC) Barcelona 08019 Spain
- Barcelona Research Center in Multiscale Science and Engineering UPC Barcelona 08019 Spain
- Institute for Bioengineering of Catalonia Barcelona 08028 Spain
| | - Carlos Mas‐Moruno
- Biomaterials, Biomechanics and Tissue Engineering Group Department of Materials Science and Engineering Universitat Politècnica de Catalunya (UPC) Barcelona 08019 Spain
- Barcelona Research Center in Multiscale Science and Engineering UPC Barcelona 08019 Spain
| |
Collapse
|
9
|
Alavi SK, Lotz O, Akhavan B, Yeo G, Walia R, McKenzie DR, Bilek MM. Atmospheric Pressure Plasma Jet Treatment of Polymers Enables Reagent-Free Covalent Attachment of Biomolecules for Bioprinting. ACS APPLIED MATERIALS & INTERFACES 2020; 12:38730-38743. [PMID: 32706575 DOI: 10.1021/acsami.0c07169] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Three-dimensional (3D) bioprinting, where cells, hydrogels, and structural polymers can be printed layer by layer into complex designs, holds great promise for advances in medicine and the biomedical sciences. In principle, this technique enables the creation of highly patient-specific disease models and biomedical implants. However, an ability to tailor surface biocompatibility and interfacial bonding between printed components, such as polymers and hydrogels, is currently lacking. Here we demonstrate that an atmospheric pressure plasma jet (APPJ) can locally activate polymeric surfaces for the reagent-free covalent attachment of proteins and hydrogel in a single-step process at desired locations. Polyethylene and poly-ε-caprolactone were used as example polymers. Covalent attachment of the proteins and hydrogel was demonstrated by resistance to removal by rigorous sodium dodecyl sulfate washing. The immobilized protein and hydrogel layers were analyzed using Fourier transform infrared and X-ray photoelectron spectroscopy. Importantly, the APPJ surface activation also rendered the polymer surfaces mildly hydrophilic as required for optimum biocompatibility. Water contact angles were observed to be stable within a range where the conformation of biomolecules is preserved. Single and double electrode designs of APPJs were compared in their characteristics relevant to localized surface functionalization, plume length, and shape. As a proof of efficacy in a biological context, APPJ-treated polyethylene functionalized with fibronectin was used to demonstrate improvements in cell adhesion and proliferation. These results have important implications for the development of a new generation of 3D bioprinters capable of spatially patterned and tailored surface functionalization performed during the 3D printing process in situ.
Collapse
Affiliation(s)
| | - Oliver Lotz
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
- School of Biomedical Engineering, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - Behnam Akhavan
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
- School of Biomedical Engineering, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - Giselle Yeo
- Charles Perkins Centre, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - Rashi Walia
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - David R McKenzie
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
- Charles Perkins Centre, The University of Sydney, Sydney, New South Wales 2006 Australia
- Sydney Nano Institute, The University of Sydney, Sydney, New South Wales 2006 Australia
| | - Marcela M Bilek
- School of Physics, The University of Sydney, Sydney, New South Wales 2006 Australia
- School of Biomedical Engineering, The University of Sydney, Sydney, New South Wales 2006 Australia
- Charles Perkins Centre, The University of Sydney, Sydney, New South Wales 2006 Australia
- Sydney Nano Institute, The University of Sydney, Sydney, New South Wales 2006 Australia
| |
Collapse
|
10
|
A multifaceted biomimetic interface to improve the longevity of orthopedic implants. Acta Biomater 2020; 110:266-279. [PMID: 32344174 DOI: 10.1016/j.actbio.2020.04.020] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2020] [Revised: 03/23/2020] [Accepted: 04/09/2020] [Indexed: 01/22/2023]
Abstract
The rise of additive manufacturing has provided a paradigm shift in the fabrication of precise, patient-specific implants that replicate the physical properties of native bone. However, eliciting an optimal biological response from such materials for rapid bone integration remains a challenge. Here we propose for the first time a one-step ion-assisted plasma polymerization process to create bio-functional 3D printed titanium (Ti) implants that offer rapid bone integration. Using selective laser melting, porous Ti implants with enhanced bone-mimicking mechanical properties were fabricated. The implants were functionalized uniformly with a highly reactive, radical-rich polymeric coating generated using a unique combination of plasma polymerization and plasma immersion ion implantation. We demonstrated the performance of such activated Ti implants with a focus on the coating's homogeneity, stability, and biological functionality. It was shown that the optimized coating was highly robust and possessed superb physico-chemical stability in a corrosive physiological solution. The plasma activated coating was cytocompatible and non-immunogenic; and through its high reactivity, it allowed for easy, one-step covalent immobilization of functional biomolecules in the absence of solvents or chemicals. The activated Ti implants bio-functionalized with bone morphogenetic protein 2 (BMP-2) showed a reduced protein desorption and a more sustained osteoblast response both in vitro and in vivo compared to implants modified through conventional physisorption of BMP-2. The versatile new approach presented here will enable the development of bio-functionalized additively manufactured implants that are patient-specific and offer improved integration with host tissue. STATEMENT OF SIGNIFICANCE: Additive manufacturing has revolutionized the fabrication of patient-specific orthopedic implants. Although such 3D printed implants can show desirable mechanical and mass transport properties, they often require surface bio-functionalities to enable control over the biological response. Surface covalent immobilization of bioactive molecules is a viable approach to achieve this. Here we report the development of additively manufactured titanium implants that precisely replicate the physical properties of native bone and are bio-functionalized in a simple, reagent-free step. Our results show that covalent attachment of bone-related growth factors through ion-assisted plasma polymerized interlayers circumvents their desorption in physiological solution and significantly improves the bone induction by the implants both in vitro and in vivo.
Collapse
|
11
|
To be a radical or not to be one? The fate of the stable nitroxide radical TEMPO [(2,2,6,6-Tetramethylpiperidin-1-yl)oxyl] undergoing plasma polymerization into thin-film coatings. Biointerphases 2020; 15:031015. [PMID: 32590900 DOI: 10.1116/6.0000259] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The stable nitroxide radical TEMPO [(2,2,6,6-Tetramethylpiperidin-1-yl)oxyl] has a multitude of applications in fields ranging from energy storage to biomedical applications and many more. However, to date, the processes of incorporating nitroxide radicals into thin-film coatings are laborious and not cost-effective, which hinders their wider use in many applications. In contrast, the authors have recently demonstrated the facile method of plasma polymerization of TEMPO into thin-film coatings that retain the stable nitroxide radicals. In this work, we are using three types of mass spectroscopic methods (plasma-mass spectrometry, time of flight secondary ion mass spectrometry, and high-performance liquid chromatography-mass spectrometry) and electron spin resonance to track the fate of the TEMPO molecule from monomer flask through the plasma and inside the resulting coatings. The results of this study demonstrate that TEMPO is a versatile monomer that can be used across different plasma reactors and reliably retain the stable nitroxide radical in the resulting thin-film coatings if certain process conditions are observed, namely, higher process pressures and lower powers.
Collapse
|
12
|
Yang N, Tan RP, Chan AHP, Lee BSL, Santos M, Hung J, Liao Y, Bilek MMM, Fei J, Wise SG, Bao S. Immobilized Macrophage Colony-Stimulating Factor (M-CSF) Regulates the Foreign Body Response to Implanted Materials. ACS Biomater Sci Eng 2020; 6:995-1007. [PMID: 33464851 DOI: 10.1021/acsbiomaterials.9b01887] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The functionality and durability of implanted biomaterials are often compromised by an exaggerated foreign body reaction (FBR). M1/M2 polarization of macrophages is a critical regulator of scaffold-induced FBR. Macrophage colony-stimulating factor (M-CSF), a hematopoietic growth factor, induces macrophages into an M2-like polarized state, leading to immunoregulation and promoting tissue repair. In the present study, we explored the immunomodulatory effects of surface bound M-CSF on poly-l-lactic acid (PLLA)-induced FBR. M-CSF was immobilized on the surface of PLLA via plasma immersion ion implantation (PIII). M-CSF functionalized PLLA, PLLA-only, and PLLA+PIII were assessed in an IL-1β luciferase reporter mouse to detect real-time levels of IL-1β expression, reflecting acute inflammation in vivo. Additionally, these different treated scaffolds were implanted subcutaneously into wild-type mice to explore the effect of M-CSF in polarization of M2-like macrophages (CD68+/CD206+), related cytokines (pro-inflammatory: IL-1β, TNF and MCP-1; anti-inflammatory: IL-10 and TGF-β), and angiogenesis (CD31) by immunofluorescent staining. Our data demonstrated that IL-1β activity in M-CSF functionalized scaffolds was ∼50% reduced compared to PLLA-only at day 1 (p < 0.01) and day 2 (p < 0.05) post-implantation. There were >2.6-fold more CD206+ macrophages in M-CSF functionalized PLLA compared to PLLA-only at day 7 (p < 0.001), along with higher levels of IL-10 at both day 7 (p < 0.05) and day 14 (p < 0.01), and TGF-β at day 3 (p < 0.05), day 7 (p < 0.05), and day 14 (p < 0.001). Lower levels of pro-inflammatory cytokines were also detected in M-CSF functionalized PLLA in the early phase of the immune response compared to PLLA-only: a ∼58% decrease at day 3 in IL-1β; a ∼91% decrease at day 3 and a ∼66% decrease at day 7 in TNF; and a ∼60% decrease at day 7 in MCP-1. Moreover, enhanced angiogenesis inside and on/near the scaffold was observed in M-CSF functionalized PLLA compared to PLLA-only at day 3 (p < 0.05) and day 7 (p < 0.05), respectively. Overall, M-CSF functionalized PLLA enhanced CD206+ macrophage polarization and angiogenesis, consistent with lower levels of pro-inflammatory cytokines and higher levels of anti-inflammatory cytokines in early stages of the host response, indicating potential immunoregulatory functions on the local environment.
Collapse
Affiliation(s)
- Nianji Yang
- Discipline of Pathology, University of Sydney, Sydney, New South Wales 2006, Australia.,Discipline of Physiology, University of Sydney, Sydney, New South Wales 2006, Australia.,The Heart Research Institute, Sydney, Australia.,Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Richard P Tan
- Discipline of Physiology, University of Sydney, Sydney, New South Wales 2006, Australia.,The Heart Research Institute, Sydney, Australia.,Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
| | | | - Bob S L Lee
- Discipline of Physiology, University of Sydney, Sydney, New South Wales 2006, Australia.,The Heart Research Institute, Sydney, Australia.,Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Miguel Santos
- Discipline of Physiology, University of Sydney, Sydney, New South Wales 2006, Australia.,The Heart Research Institute, Sydney, Australia.,Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Juichien Hung
- Discipline of Physiology, University of Sydney, Sydney, New South Wales 2006, Australia.,The Heart Research Institute, Sydney, Australia.,Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Yun Liao
- Department of Pharmacy, Tongren Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Marcela M M Bilek
- Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia.,School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Jian Fei
- School of Life Science and Technology, Shanghai Tongji University, Shanghai, China.,Research Centre for Model Organism, Shanghai, China
| | - Steven G Wise
- Discipline of Physiology, University of Sydney, Sydney, New South Wales 2006, Australia.,The Heart Research Institute, Sydney, Australia.,Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
| | - Shisan Bao
- Discipline of Pathology, University of Sydney, Sydney, New South Wales 2006, Australia.,Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|